Poster winners named

0331-PostersThe American Academy of Dermatology Poster Exhibits Task Force is pleased to announce the recipients of the 2015 Poster Awards

First Place

1740: N-acetylcysteine S-nitrosothiol Nanoparticles Prevent Wound Expansion and Accelerate Wound Closure in a Murine Burn Model

Angelo Landriscina, Montefiore Medical Center, Bronx, NY, United States; Jamie Rosen, Montefiore Medical Center, Bronx, NY, United States; Tagai Musaev, Montefiore Medical Center, Bronx, NY, United States; Joshua Nosanchuk, MD, Albert Einstein College of Medicine, New York, NY; Adam Friedman, MD, Montefiore Medical Center, Bronx, NY, United States

Second Place

1296: Serum Potassium Monitoring Is Not Indicated for Healthy Young Female Patients on Spironolactone for Acne

Qing Yu Weng, Harvard Medical School, Boston, MA, United States; Molly Plovanich, MD, Brigham and Women’s Hospital, Boston, MA, United States; Arash Mostaghimi, MD, MPA, Brigham and Women’s Hospital, Boston, MA, United States

Third Place

1244: The Prevalence of Burning Mouth Syndrome: A Population-Based Study

John Kohorst, Mayo Clinic Medical School, Rochester, MN, United States; Alison Bruce, MBChB, Mayo Clinic, Rochester, MN, United States; Rochelle Torgerson, MD, PhD, Mayo Clinic, Rochester, MN, United States; Mark Davis, MD, Mayo Clinic, Rochester, MN, United States

Fourth Place

1389: First-in-Human Phase 1 Safety Study of BLZ-100 in Subjects With Skin Cancer

Dennis Miller, PhD, Blaze Bioscience, Seattle, WA, United States; Miko Yamada, PhD, Dermatology Research Center, Brisbane, Australia; Melinda Lowe, PhD, Medicines Development, Melbourne, Australia; Casey Rowe, MBBS, Q-Pharm Pty Ltd, Brisbane, Australia; Dominic Wood, MBBS, IQ Pathology, Brisbane, Australia; Tarl Prow, PhD, Dermatology Research Center, Brisbane, Australia; Lynda Spelman, MBBS, Veracity Clinical Research, Brisbane, Australia

Honorable Mention

2020: Two Phase 3 Studies of Oral Tofacitinib in Patients with Moderate to Severe Plaque Psoriasis: 16-Week Efficacy and Safety Results

Kim A. Papp, MD, Probity Medical Research and K. Papp Clinical Research Inc, Waterloo, Ontario, Canada; Martin A. Menter, MD, Baylor Research Institute, TX, United States; Masatoshi Abe, MD, PhD, Gunma University Hospital, Japan; Boni E. Elewski, MD, University of Alabama, AL, United States; Steven R. Feldman, MD, PhD, Wake Forest University, NC, United States; Alice G. Gottlieb, MD, PhD, Tufts Medical Center, Boston, MA, United States; Diamant Thaci, MD, PhD, University Hospital Schleswig-Holstein, Kiel, Germany; Thomas Luger, MD, PhD, Department of Dermatology, University of Munster, Munster, Germany; Svitlana Tatulych, MD, Pfizer Inc, Groton, CT, United States; Pankaj Gupta, PhD, Pfizer Inc, Groton, CT, United States; James Proulx, MD, Pfizer Inc, Groton, CT, United States; Shu-Ping Lan, MS, MPH, Pfizer Inc, Groton, CT, United States; Robert Wolk, MD, PhD, Pfizer Inc, Groton, CT, United States

Award Nominees are selected and judged from a pool of the highest scoring abstracts submitted for poster presentation. Congratulations to the authors on their exceptional work.

Return to index 

Top